As part of the leadership transition at Dana-Farber Cancer Institute, Kevin Haigis has assumed the position of Chief Scientific Officer. Kevin joined Dana-Farber earlier this year as Chief Research Officer, where he has overseen the operation of Dana-Farber’s research program, planning, and implementing our overall scientific strategy through the difficult period of the COVID-19 pandemic.